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During viral infection, the virus and host must compete for resources inside the 
cell. One of these resources is polyamines. Polyamines are small, positively charged 
molecules that are found in all eukaryotic cells. They play a key role in several cellular 
functions including growth and proliferation, transcription and translation, and 
membrane stability. Viruses also rely polyamines for productive replication, utilizing 
them during DNA/RNA polymerization, nucleic acid packaging, and protein synthesis. In 
response to a virus infecting a host cell, the host cell will begin to regulate polyamine 
levels as a way to combat the infection. Polyamine levels are regulated by several 
different enzymes, including SAT1. SAT1 acetylates polyamines to form acetyl 
derivatives leading to degradation or excretion of the polyamines and therefore, 
rendering them useless to the virus. The virus, in turn needs to combat this to continue 
infection. Recent studies suggest that one way the virus does this is by splicing the 
polyamine regulatory enzymes’ genes before they can be transcribed. We found that 
Zika virus, a flavivirus, may alter SAT1 splicing and activity. We hypothesize that ZIKV 
induced alternative splicing of the SAT1 gene generates an enzyme that is 






Review of Literature 
Zika Virus: An Overview 
 Zika virus (ZIKV) has recently gained a lot of attention due to the 2016 outbreak 
in which the virus spread to over 80 countries becoming the focus of a public health 
emergency. ZIKV was first isolated in 1947 at Yellow Fever Research Institute in Zika 
Forest, Uganda. Until 2007, only 14 human cases were identified, and these originated 
in Southeast Asia and Africa (1). The first outbreak of the virus occurred in Yap (Federal 
States of Micronesia) in 2007. Due to the similarities of clinical symptoms, the disease 
was originally diagnosed as chikungunya, dengue, or Ross River disease until 
specimens from patients revealed the RNA of ZIKV. Approximately 73% of Yap’s 
population was infected in this outbreak (2). Since then outbreaks have occurred in 
French Polynesia (3), New Caledonia, Easter Island, the Cook Islands, and numerous 
Latin American countries. By March of 2015, Brazil had between 500,000-1,500,000 
ZIKV cases (4). By 2016, the World Health Organization declared ZIKV disease a public 
health emergency of international concern. As of 2018 a total of 86 countries have 
reported evidence of ZIKV disease (Figure 1). Since then the number of infections has 





Figure 1. Reported Cases of ZIKV. 
The map indicates reported cases of ZIKV infection in 2017. The purple represents 
areas with active transmission in 2017, the orange represents areas affected in 2017, 
and the yellow represents areas with ZIKV infection reported before 2015 (5).  
 ZIKV is an arbovirus and is spread primarily by Aedes mosquitos, however some 
reports have found Anopheles, Ertmapodites (6), Culex, and Mansonia (7) species can 
also be vectors. ZIKV can also be transmitted by blood transfusion, sexual contact, and 
vertically from mother to child during pregnancy (8) (Figure 2). Most cases present 
symptoms 3-12 days after infection. Nearly 80% of cases are asymptomatic. Case 
fatalities and severe illness are rare consequences of ZIKV infection. Symptoms tend to 
be non-specific, mild, and self-limiting. They include mild fever, dermatological rashes, 
joint pain, and headache. The most common of these symptoms is the skin rash which 
is seen in 90% of cases and often lasts 4-5 days. Hospitalization from ZIKV infection is 
rare (9).  
 The major complications associated with ZIKV infection is congenital 




in which the immune system damages nerves resulting in muscle weakness and 
sometimes paralysis. This is due to high levels of protein in the cerebrospinal fluid (10). 
In regions affected by the ZIKV epidemic, the incident rate of Guillain-Barre syndrome 
was 20-fold higher than that of not affected areas (2). Primary microcephaly is defined 
as a head circumference more than 3 standard deviations below the mean at birth. 
Symptoms include hearing loss, development delay, seizure disorder, and cerebral 
palsy. The risk of microcephaly is greatest in the first trimester of pregnancy. 
Researchers have reported ZIKV in amniotic fluid and in placental cells (11). ZIKV first 
infects the placenta and then the neural progenitor cells in the developing fetus. This 
decreases the neural progenitor cells viability and growth through down-regulation of 
genes involved in cell and organ development and up-regulation of genes involved in 
immune responses. This ultimately results in inhibited cellular proliferation and 







Figure 2. Transmission of ZIKV.  
Arrows represent transmission direction. Transmission of ZIKV is primarily by mosquito 
bites but instances of sexual transmission have been reported as have cases of 
infection by blood transfusion. ZIKV can also be passed from mother to fetus in the 
womb.  
 ZIKV is a member of the Flaviviridae family. Other members include dengue 
virus, West Nile virus, and yellow fever virus. Like all members of this family, ZIKV has a 
positive sense single stranded RNA genome approximately 11 kb in size. ZIKV is 
spherical in shape with an icosahedral like arrangement of surface proteins and is 
approximately 50nm in diameter. The RNA of the virion is infectious and acts as viral 
mRNA and viral genome (13).  
 The lifecycle of ZIKV follows that of most flaviviruses. The virus enters the cells 
when the virion attaches to the cell membrane of the host via an envelope protein that 
induces endocytosis. Once inside the host cell, the viral membrane fuses with the 




translated into a polyprotein which is involved in the formation of all structural and non-
structural proteins. Replication of the RNA then occurs in the cytoplasmic viral factories 
of the ER which produces double stranded RNA. This double stranded RNA then 
undergoes transcription to form additional single stranded RNA. This new single 
stranded RNA is then assembled in the ER to form new virions. These virions are 
ultimately transferred to the Golgi and released and go on and infect new cells (14) 
(Figure 3). ZIKV, as for all viruses, relies on host machinery and resources during its 
replication. 
 
Figure 3. Flavivirus Replication Cycle.  
The virus enters the cells when the virion attaches to the cell membrane of the host via 
an envelope protein that encourages endocytosis. The viral membrane fuses with the 
endosomal membrane and the RNA is released into the cytoplasm. This RNA is then 
translated into a polyprotein which is involved in the formation of all structural and non-
structural proteins. Replication of the RNA then occurs in the cytoplasmic viral factories 
of the ER which produces double stranded RNA. This double stranded RNA then 
undergoes transcription to form additional single stranded RNA. This new single 
stranded RNA is then assembled in the ER to form new virions. These virions are 





 Polyamines are small, positively charge molecules found in all cells. They consist 
of flexible carbon chains with positively charged amino groups. Polyamines are involved 
in diverse cellular processes including protein synthesis, RNA folding, membrane 
interactions, protein-RNA interactions, DNA structure, and gene expression(16, 17). 
Mammalian cells synthesize three biogenic polyamines: putrescine, spermidine, and 
spermine. All three polyamines are synthesized through the same pathway. The first 
step occurs when arginine is converted to ornithine. Ornithine is then converted into 
putrescine via the gatekeeping enzyme of the pathway, ornithine decarboxylase 1 
(ODC1). Putrescine is then converted to spermidine by the enzyme spermidine 
synthase (SRM). Spermidine is ultimately converted to spermine via the enzyme 
spermine synthase (SMS)(18). The cell exerts a significant amount of energy in 
maintaining polyamine homeostasis. This is done through synthesis, degradation, 
import, and export of polyamines. This homeostasis is maintained by the enzymes 
polyamine oxidase (PAOX), ODC1 antizyme (OAZ1), and spermidine/spermine 






Figure 4. Biosynthesis Pathway of Polyamines.  
Polyamine synthesis begins with arginine being converted into ornithine. ODC1, the 
rate-limiting enzyme, converts ornithine to putrescine. Putrescine is converted to 
spermidine via SRM. Spermidine is converted to spermine via SMS and converted back 
via SMOX. Spermine and spermidine can be acetylated by SAT1 and converted back to 
putrescine via PAO. Image adapted and modified from(20). 
 Considering the importance of polyamines in cellular processes, it is not 
surprising that viruses also utilize polyamines during their lifecycle (18). Viruses rely on 
polyamines for numerous stages in the viral life cycle including genome packaging, 
DNA-dependent RNA polymerization, genome replication, and viral protein translation. 
DNA viruses like herpes simplex 1 (HSV1) and human cytomegalovirus (HCMV) have 
been shown to rely on polyamines for replication (21, 22). Vaccinia virus has also been 
shown to rely on polyamines in a late step of its viral lifecycle (23). The role of 
polyamines in RNA viruses has been demonstrated in several different virus families 
including alphaviruses, enteroviruses, bunyaviruses, and flaviviruses (24, 25). 
Bunyaviruses, La Crosse virus (LACV) and Rift Valley fever virus (RVFV), have been 
shown to generate noninfectious viral particles when polyamines are deleted from the 




were depleted from the cell making the polyamine pathway a possible target for limiting 
viral infections(18). 
SAT1 
 Spermidine/spermine acetyltransferase (SAT1) is the rate-limiting enzyme in the 
interconversion of polyamines. SAT1 works by acetylating spermidine and spermine 
which results in their degradation or excretion from the cell. SAT1 uses acetyl-CoA to 
acetylate the aminopropyl end of these higher level polyamines. In the presence of high 
levels of polyamines, transcription and translation of SAT1 are increased. SAT1 has 
been shown to be induced in response to many different agents and pathophysiological 
conditions including polyamines analogs such as N1, N1 -diethylnorspermine (DENSpm) 
and the interferon response (24, 27). The interferon response, which is the innate 
immune response to viral infection, initiates a series of signaling events that results in 
the expression of interferon-stimulated genes (ISGs), including SAT1, to counteract viral 
infection. Studies have shown that SAT1 is upregulated with interferon beta treatment of 
cells, which results in the depletion of polyamines from the cell and limits viral infection 
(24).  
SAT1 is regulated, by polyamines and their analogs, at many different levels of 
gene expression including transcription and stabilization of messenger RNA (mRNA). 
The Sat1 gene contains six exons that encode mRNAs of 1.3 and 1.5 kb. SAT1 pre-
mRNA has been shown to undergo alternative splicing to yield a longer variant (SAT1-
X). Studies have shown that inclusion of this exon is inhibited by polyamines and their 
analogs resulting in a stable and correct mRNA. This longer variant has an additional 




termination codons which marks it for nonsense mediated mRNA decay (28) (Figure 5). 
Previous studies have shown that SAT1-X mRNA is accumulated upon various factors 
including X-ray irradiation (29), iron chelation, hypoxia (30), and infection with 
Venezuelan equine encephalitis virus and tick-borne encephalitis virus (31). However, it 
is unknown if this longer SAT1 variant is induced upon ZIKV infection.  
 
Figure 5. Alternatively Spliced SAT1.  
SAT1 has been shown to be alternatively spliced to yield a longer variant. This is due to 
the addition of an exon about 110 bp long between exons 3 and 4 indicated in purple. 
This additional exon introduced three premature termination codons indicated in red.   
The normal SAT1 transcript encodes a protein of about 171 amino acids. Due to 
the presence of three premature stop codons, the alternatively spliced variant is only 
capable of producing a 71 amino acid polypeptide (31) (Figure 6). It has been reported 
that 68 amino acid residues of the N-terminus of the tSAT1 are identical to the full-
length SAT but due to a shift in the reading frame from the addition 110 bp, tSAT1 has a 
new C-terminus. This reconstructed C- terminus of tSAT1 lacks both the acetyl-CoA 
binding and catalytic motifs which are essential for polyamine regulation (30). Thus, it is 





Figure 6. Truncated SAT1 Protein 
The normal SAT1 transcript encodes a protein of about 171 amino acids, SAT1-X is 
only capable of producing a 71 amino acid polypeptide. This truncated polypeptide 
(tSAT1) is the result of a reading frame shift that introduces three premature stop 
codons (31).  
Hypothesis and Aims  
 Studies have shown that RNA viruses, such as ZIKV, rely on polyamines for 
replication and depletion of these polyamines results in decreased viral replication. It 
has also been shown that SAT1 is induced upon the interferon response to viral 
infection. SAT1 reduces polyamine levels in the cell by acetylating spermidine and 
spermine, marking them for degradation or excretion. This ultimately restricts viral 
replication by depleting the cell of polyamines (24). Furthermore, studies have shown 
that SAT1 can be alternatively spliced in response to polyamine analogs and other 
pathophysiological agents including some RNA viruses (31). This alternative splice 
variant introduces three premature termination codons which results in nonsense 
mediated mRNA decay (28). We hypothesized that ZIKV induces alternative splicing of 
SAT1, generating an enzyme that is nonfunctional and thus allowing robust virus 
infection by disrupting polyamine depletion.  
 In AIM 1, we measured SAT1 induction and its effects on polyamine levels during 




there would be a decrease in polyamine levels due to SAT1 activation. The results from 
this aim determined how viral infection and polyamine catabolism interrelate.  
 In AIM 2, we determined the mechanism of SAT1 inactivation during viral 
infection. I hypothesized that ZIKV was inducing alternative splicing of SAT1, creating 
the longer variant carrying three premature termination codons. The results from this 
aim determined how ZIKV may be inhibiting SAT1 function. 
 In AIM 3, we measured SAT1 splicing in multiple cell types and with different 
viruses. I hypothesized that that immune signaling would play an important role in the 
induction of SAT1 and that this would be a conserved mechanism for viruses from 
different families. The results from this aim determined if SAT1 alternative splicing is 
induced through interferon signaling.  
 The data generated from these aims will define a novel interaction between host 
cells and ZIKV. We see that ZIKV does induce alternative splicing of SAT1 which 




MATERIALS AND METHODS 
Cell Culture 
Cells were maintained at 37⁰C in 5% CO2, in Dulbecco’s modified Eagle’s 
medium (DMEM; Life Technologies) with bovine serum and penicillin-streptomycin. 
Vero cells (BEI Resources) were supplemented with 10% new-born calf serum (NBCS; 
Thermo-Fisher) and Huh7 cells, kindly provided by Dr. Susan Uprichard, were 
supplemented with 10% fetal bovine serum (FBS; Thermo-Fisher). THP1 cells were 
donated by Dr. Makio Iwashima and maintained in RPMI (Thermo-Fisher) 
supplemented with 2% FBS and beta-mercaptoethanol (BME, 50mM; Thermo-Fisher). 
THP1’s were differentiated with phorbol 12-myristate 13-acetate (PMA, 100 pg/ mL; 
Thermo-Fisher). 
Drug Treatment 
N1,N11-Diethylnorspermine (DENSpm; Santa Cruz Biotechnology) were diluted 
to 100x solution (100mM and 10mM, respectively) in sterile water. Cells were treated 
with 100uM of DENSpm 24 hours before, 2 hours after, and 4 hours after infection. 
During infection, media was cleared and saved from the cells. The same medium 
containing DENSpm was then used to replenish the cells following infection. Cells were 





Infection and Enumeration of Viral Titers 
RVFV and LACV were derived from the first passage of virus in Huh7 cells. ZIKV 
(MR766) was derived from the first passage of virus in Vero cells. ZIKV and LACV were 
obtained from Biodefense and Emerging Infections (BEI) Research Resources. For all 
infections, DENSpm was maintained throughout infection as designated. Viral stocks 
were maintained at -80⁰C. For infection, virus was diluted in serum-free DMEM for a 
multiplicity of infection (MOI) of 5 on Huh7 cells, unless otherwise indicated. Viral 
inoculum was overlain on cells for 10 to 30 minutes, and the cells were replenished with 
media. Supernatants were collected from MP-12, LACV,  and ZIKV 24 hpi. Dilutions of 
cell supernatant were prepared in serum-free DMEM and used to inoculate confluent 
monolayer of Vero cells for 10 to 15 min at 37⁰C. Cells were overlain with 0.8% agarose 
in DMEM containing 2% NBCS. MP-12, ZIKV, and LACV samples incubated for 3 days 
at 37⁰C. Following incubation, cells were fixed with 4% formalin and revealed with 
crystal violet solution (10% crystal violet; Sigma-Aldrich). Plaques were enumerated and 
used to back-calculate the number of plaque forming units (pfu) per milliliter of collected 
volume. 
Thin Layer Chromatography Determination of Polyamines 
Polyamines were separated by thin-layer chromatography as previously 
described (Madhubala, 1998). For all samples, cells were treated as described prior to 
being trypsinized and centrifuged. Pellets were washed with PBS and then resuspended 
in 200 uL 2% perchloric acid. Samples were then incubated overnight at 4⁰C. 200 uL of 
supernatant was combined with 200 uL 5 mg/ml dansyl chloride (Sigma Aldrich) in 




overnight at room temperature. Excess dansyl chloride was cleared by incubating the 
reaction with 100 µL 150 mg/mL proline (Sigma Aldrich). Dansylated polyamines were 
extracted with 50 µL toluene (Sigma Aldrich) and centifuged. 5 µL of sample was added 
in small spots to the TLC plate (silica gel matrix; Sigma Aldrich) and exposed to 
ascending chromatography with 1:1 cyclohexane: ethylacetate. Plate was dried and 
visualized via exposure to UV.  
RNA Purification and cDNA Synthesis  
 Cells were collected in Trizol reagent (Zymo Research). RNA was purified with a 
phenol-chloroform extraction, DNase treated (Invitrogen), and used for cDNA synthesis 
using Multiscribe reverse transcriptase (Applied Biosystems), with 500 ng RNA and 
random hexamer primers. 
Gene Expression Analysis 
 RNA from cells was collected and purified. Gene expression was analyzed by 
quantitative real-time PCR with SYBR Green (DotScientific) using a one-step protocol 
using QuantStudio 3 (ThermoFisher Scientific). Relative gene expression was 
calculated using the ΔCT method, normalized to GAPDH qRT-PCR control. Primers 
were verified for linearity using eight-fold serial diluted cDNA and checked for specificity 
via melt curve analysis following by agarose gel electrophoresis.  
Splicing Analysis  
 RNA from cells was collected and purified. Splicing was analyzed by real-time 
PCR with DreamTaq (DotScientific) using SimpliAmp Thermal Cycler (Applied 
Biosystems by Life technologies). PCR product was analyzed by agarose gel 




Table 1. Primers Used in This Study 
Western Blots 
Samples were collected with Bolt LDS Buffer and Bolt Reducing Agent 
(Invitrogen) and run on polyacrylamide gels. Gels were transferred using the semi-dry 
transfer method. Membranes were probed with primary antibody for GAPDH (1:5000, 
proteintech) and SAT1 (1:100, Santa Cruz Biotechnology). Membranes were treated 
with SuperSignal West Pico PLUS Chemiluminescent Substrate (ThermoFisher 
Scientific) and visualized on ProteinSimple FluorChem E imager.  
Polyamine Luciferase Reporter Assay 
To measure free polyamine levels in cells, a dual-luciferase vector containing the 
wild-type -1 frameshift antizyme OAZ1 (pC5730), were transfected into cells with 
LipoD293 (SignaGen). Free polyamines modulate OAZ1 mRNA frameshifting and these 
constructs can measure relative endogenous polyamine concentrations via a dual-
luciferase reporter as previously described (32). Huh7 cells were seeded with 2% media 
and drug treated as described above. Cells were transfected with 62.5 ng of reporter 
plasmid of and after 24 hours of incubation, luminescent signal was measured using the 
Dual-Luciferase Reporter Assay System (Promega) by measuring both firefly and 
Primers Forward Reverse 
SAT1  5’-GAAGAGGTGCTTCTGATCTGTC-3’ 5’-CTCACTCCTCTGTTGCCATTT-3’ 
tSAT1 5’-GTCTCTAGCTTCGCCATGTA-3’ 5’-CTAGGAAATGTGTTATTTCATC-3’ 
ZIKV 5’-CCCTCAAGTATAGCAGCAAGAG-3’ 5’-TGAGTTGGAGTCCGGAAATG-3’ 




Renilla luciferase with the Veritas Microplate Luminometer (Turner Biosystems). Firefly 
luciferase was normalized to Renilla and the wild-type values and subsequently 
normalized to untreated controls.  
Transfection of Plasmids 
 Primers were designed to target SAT1 with overlapping ends. Gibson assembly 
was used to generate plasmid with tetracycline promoter.   
Quantification and Statistical Analysis 
Prism 6 (GraphPad) was used to generate graphs and perform statistical 
analysis. For all analyses, one-tailed Student’s t test was used to compare groups, 
unless otherwise noted in figure legends, with a = 0.05. For tests of sample proportions, 
p values were derived from calculated Z scores with two tails and a = 0.05. Correlations 
between SAT1 expression and viral titer were calculated using either the linear 
regression or exponential growth curve fitting function of Prism. Statistical details are 
noted in individual figure legends. Mean and standard error of the mean are shown in 








SAT1 is Induced Upon Viral Infection 
 The interferon response, triggered by viral infection, leads to a series of signaling 
events that results in the expression of interferon stimulated genes (ISGs). These ISGs 
counteract the viral infection in several different ways, including degrading viral mRNA, 
altering membranes, and inducing apoptosis. Studies have shown that SAT1 is 
upregulated in response to interferon beta treatment of cells (24). To investigate if SAT1 
is induced upon viral infection, we infected PMA derived macrophages (THP1) with 
ZIKV, LACV, or the vaccine strain of RVFV at a multiplicity of infection (MOI) of 5 plaque 
forming units (pfu) per cell. Samples were collected after 24 hours and SAT1 induction 
was measured via qRT-PCR with SAT1 specific primers. We observed a significant 
increase in SAT1 gene expression in cells infected with virus (Figure 7A). This 
experiment was also done in huh7 cells. We observed a similar phenotype in which 
SAT1 gene expression was significantly increased in cells infected with virus (Figure 
7B). This suggests that SAT1 is induced in response to infection with ZIKV, LACV, and 
RVFV.  
 SAT1 is the rate-limiting enzyme in the interconversion of polyamines. SAT1 
works by acetylating spermidine and spermine, which results in their degradation or 
excretion from the cell (18). Since SAT1 is induced upon viral infection, we sought to 




we hypothesized that the higher-level polyamines (spermine and spermidine) would not 
be present in infected cells. We infected THP1 cells with ZIKV, LACV, or RVFV at a 
MOI of 5 and collected after 24 hours and performed thin-layer chromatography (TLC) 
on polyamines. We found that, compared to our positive control of DENSpm treated 
cells, which showed no spermine or spermidine, virus infected cells still had these 
higher-level polyamines present (Figure 7C). This suggests that while SAT1 is induced 
transcriptionally upon viral infection, it is not functioning to acetylate spermine or 










Figure 7. SAT1 is Induced Upon Viral Infection. 
(A) THP1 cells were infected with ZIKV, LACV, or RVFV at a MOI of 5. Samples were 
collected after 24 hours. Following RNA purification, SAT1 gene expression was 
measure via qRT-PCR and normalized to cellular β-Actin. (B) Huh7 cells were infected 
with ZIKV, LACV, or RVFV at a MOI of 5 and collected after 24 hours. Following RNA 
purification, SAT1 gene expression was measured via qRT-PCR. (C) Thin layer 
chromatography on THP1 cells infected as in (A) to measure biogenic polyamine levels. 
Values provided above data bars represent the fold change compared to untreated 
conditions. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 using Student’s t test (n ≥ 3) comparing 
infection to uninfected controls. Error bars represent ± 1 SEM. Statistical comparison 
were performed between infected and uninfected conditions.  
DENSpm-mediated SAT1 Induction Does Not Alter Viral Replication After 
Infection Initiates 
 Previous studies have shown that flaviviruses, including ZIKV, rely on 
polyamines for a productive infection (25). Our data suggests that, even though SAT1 is 




polyamines marking them for excretion or degradation. We sought to see the effects on 
viral replication if we forced the expression of SAT1 using DENSpm. DENSpm is a 
polyamine analog and induces SAT1. We treated THP1 cells with 100 μM DENSpm 
either 24 hours before, 2 hours after, or 4 hours after infection with ZIKV at a MOI of 5. 
After 24 hours, we titered the samples on Vero-E6 cells. We found that, compared to 
our not treated samples, the samples treated with DENSpm 24 hours before infection 
had a decrease in viral replication indicating the antiviral effects of SAT1. However, 
when cells are treated with DENSpm 2- or 4-hours after infection, the viral titers have 
not decreased when compared to not treated samples (Figure 8A). This was repeated in 
Huh7 cells and the same phenotype was observed, when cells were treated before 
infection, the viral titers were decreased but when the cells were treated at either time 
point after infection, the viral titers did not decrease (Figure 8B). To visually confirm that 
it is the polyamine levels being affected by the DENSpm treatment, we performed a 
TLC on samples from THP1 cells. The cells were once again treated with 100 μM 
DENSpm 24 hours before, at the time of infection, 2 hours after, or 4 hours after 
infection with ZIKV. The samples were collected after 24 hours and TLC on the 
polyamines was performed. We found that when cells are treated with 100 μM DENSpm 
24 hours before infection, there is no spermidine or spermine in the samples. When 
cells are treated at or after infection however, spermidine and spermine are present in 
the samples (Figure 8C). This is suggesting that if SAT1 is induced after viral infection 
has initiated, it is not acetylating spermidine and spermine, marking them for excretion 





Figure 8. DENSpm-mediated SAT1 Induction Does Not Alter Polyamine Levels 
After Infection Initiates. 
(A) THP1 cells were treated with DENSpm 24 hours before, 2 hours after, or 4 hours 
after infection with ZIKV. Samples were collected after 24 hours and titered via plaque 
assay. (B) Huh7 cells were treated with DENSpm 24 hours before, 2 hours after, and 4 
hours after infection with ZIKV. Samples were collected after 24 hours and titered via 
plaque assay. (C) Thin layer chromatography on cells treated and infected as in (A) to 
measure biological polyamine levels. Values provided above data bars represent the 
fold change compared to untreated conditions. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 using 
Student’s t test (n ≥ 3) comparing DENSpm treated to untreated controls. Error bars 
represent ± 1 SEM. Statistical comparison were performed between treated and 
untreated conditions. 
 To ensure that SAT1 is being induced in these samples, we performed the same 
time of DENSpm addition as before on THP1 cells and collected the samples 24 hours 
after infection with ZIKV. We then measured SAT1 induction via qRT-PCR using SAT1 
specific primers. We found that in all samples treated with DENSpm, there was an 
induction of SAT1 compared to not treated samples (Figure 9A). This indicates that, 
regardless of when samples are treated with DENSpm relative to viral infection, SAT1 is 




same experimental setup. We found that when cells are treated with DENSpm before 
infection there is SAT1 present but after infection the amount of SAT1 protein seems to 
decrease with time (Figure 9B). The cause and effect of this is unclear at this time and 
further investigation is needed. Together, these data suggests that, once virus infection 
is initiated, SAT1 is induced, yet its induction does not result in the exportation or 
degradation of spermidine and spermine and therefore, is not antiviral.  
 
Figure 9. SAT1 is Induced Upon DENSpm Treatment After Infection is Initiated. 
(A) THP1 cells were treated with DENSpm 24 hours before, 2 hours after, or 4 hours 
after infection with ZIKV. Samples were collected after 24 hours and gene expression 
was measured via qRT-PCR and normalized to cellular β-Actin. (B) Western blot 
analysis of samples treated and infected as in (A). Values provided above data bars 
represent the fold change compared to untreated conditions. *p ≤ 0.05, **p ≤ 0.01, ***p 
≤ 0.001 using Student’s t test (n ≥ 3) comparing DENSpm treated to untreated controls. 
Error bars represent ± 1 SEM. Statistical comparison were performed between treated 
and untreated conditions. 
SAT1 Splicing is Altered with Infection 
 SAT1 is regulated by polyamines at many different levels of gene expression, 
including transcription and stabilization of mRNA. Previous studies have shown that 




longer variant (SAT1-X) by insertion of an additional exon between exons 3 and 4. The 
additional exon carries three pre-mature stop codons, marking it for nonsense-mediated 
RNA decay (Figure 5) (28). This variant has been shown to be induced by tick-borne 
encephalitis virus and Venezuelan equine encephalitis virus, both of which are RNA 
viruses (31). We hypothesized that ZIKV also induces the alternative splicing of SAT1 to 
generate a nonfunctional enzyme and prevent the degradation of polyamines. To test 
this hypothesis, we performed a time course of ZIKV infection. We infected THP1 cells 
and collected samples 2 hours, 4 hours, 8 hours, 16 hours, and 24 hours after infection 
followed by RNA purification and qRT-PCR using primers specific to SAT1 and SAT1-X, 
the alternatively-spliced variant. We found that, as expected, as infection progressed 
there was an increase in SAT1 expression (Figure 10A). We also found that as infection 
progressed, there was also an increase of SAT1-X expression (Figure 10B). To 
visualize this, we also performed RT-PCR with primers specific for SAT1 on these 
samples. We found that all samples had SAT1, however as the infection progresses, we 
found the presence of an additional SAT1 band (Figure 10C). This band is about 110 bp 
larger than the normal SAT1 band suggesting it is SAT1-X. This suggests that ZIKV 
infection does result in alternative splicing of SAT1 to produce a larger variant by 





Figure 10. SAT1 Splicing is Altered with ZIKV Infection.  
(A) THP1 cells were infected with ZIKV and samples were collected after 2 hours, 4 
hours, 8 hours, 16 hours, and 24 hours. RNA was purified and total SAT1 gene 
expression was measured via qRT-PCR and normalized to β-Actin and uninfected cells. 
(B) qRT-PCR with primers specific to SAT1-X was performed on samples from (A).  
(C) RT-PCR was performed on samples from (A) and run on an agarose gel. Values 
provided above data bars represent the fold change compared to untreated conditions. 
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 using Student’s t test (n ≥ 3) comparing infection to 
uninfected controls. Error bars represent ± 1 SEM. Statistical comparison were 
performed between infected and uninfected conditions.  
 We further explored this phenotype in LACV and RVFV as well as Huh7 cells. 
Our previous data showed that SAT1 is induced in LACV and RVFV infections, but the 
polyamine levels were not altered by expression. We hypothesized that infection with 




cells with LACV or RVFV and collected samples after 24 hours. We purified RNA and 
performed qRT-PCR using SAT1-X specific primers. We found that both viruses 
induced the expression of SAT1-X in THP1, specifically RVFV had a high induction of 
this variant (Figure 11A). We found infection with these viruses also results in the 
expression of SAT1-X in Huh7 cells as well (Figure 11B). To visualize this, we 
performed RT-PCR on these THP1 samples and ran them on an agarose gel. We found 
the presence of an additional band about 110 bp larger than the standard SAT1 band, 
indicating the presence of the additional exon (Figure 11C). These data suggests that 
this phenotype is not specific to ZIKV and that RVFV and LACV infections also results in 
the alternative splicing of SAT1 to generate a nonfunctional enzyme that does not alter 







Figure 11. SAT1 Splicing is Altered with LACV and RVFV Infection. 
(A) THP1 cells were infected with ZIKV, LACV, or RVFV and collected after 24 hours. 
RNA was purified and SAT1-X expression was measured via qRT-PCR and normalized 
to β-Actin and uninfected. (B) Huh7 cells were infected with ZIKV, LACV, or RVFV and 
collected after 24 hours. RNA was purified and SAT1-X expression was measured via 
qRT-PCR. (C) RT-PCR was performed on samples from (A) and run on an agarose gel. 
Values provided above data bars represent the fold change compared to untreated 
conditions. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 using Student’s t test (n ≥ 3) comparing 
infection to uninfected controls. Error bars represent ± 1 SEM. Statistical comparison 
were performed between infected and uninfected conditions. 
Alternatively Spliced SAT1 is Not Antiviral 
 Our previous data has shown that SAT1 is alternatively spliced with viral 
infection. This splice variant introduces an additional 110 bp exon between exons 3 and 




ultimately marking the mRNA for nonsense-mediated mRNA decay (28). While the N-
terminus of tSAT1 is identical to SAT1, the C-terminus lacks both the acetyl-CoA and 
catalytic motifs required for polyamine regulation (30). Therefore, we hypothesized that 
tSAT1 would not be antiviral due to its inability to acetylate polyamines marking them for 
degradation. Using the process of Gibson assembly, we were able to generate a 
plasmid carrying tSAT1. To investigate tSAT1’s effects on polyamine levels, we 
transfected increasing amounts of tSAT1 plasmid into 293T cells and measured 
polyamine levels using a quantitative polyamine-sensitive luciferase assay. We found 
that regardless of how much tSAT1 plasmid we transfected in, there was no reduction in 
polyamine levels (Figure 12A). This suggests that tSAT1 does not reduce polyamine 
levels in the cell. We further wanted to look at the tSAT1’s effects during virus infection. 
To do this, we transfected cells with 100ng of tSAT1 along with 100 ng of ZIKV full-
length infectious clone plasmids. After 24 hours, we measured ZIKV viral genomes via 
qPCR. We found that while SAT1 decreased the amount of viral genomes, tSAT1 had 
no effect when compared to controls (Figure 12B). These data suggest that tSAT1 is not 







Figure 12. tSAT1 Does Not Reduce Polyamine Levels and is Not Antiviral.  
(A) 293T cells were transfected with 100 ng, 500 ng, or 1000 ng of tSAT1 plasmid and 
intracellular polyamine levels were measured using dual luciferase assay reporter of an 
OAZ1 transcript construct. Relative luciferase activity was normalized to untransfected 
cells. (B) Huh7 cells were transfected with 100 ng of tSAT1 plasmid and 100 ng of ZIKV 
protein plasmids, viral genome was measured with qRT-PCR and normalized to 
untransfected samples. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 using Student’s t test (n ≥ 3) 
comparing untransfected cells to transfected cells. Error bars represent ± 1 SEM. 








ZIKV Induces Alternative Splicing of SAT1 
Previous studies have shown that RNA viruses, such as ZIKV, rely on 
polyamines for replication and depletion of these polyamines results in decreased viral 
replication. It has also been shown that SAT1 is induced upon the interferon response 
to viral infection. SAT1 reduces polyamine levels in the cell by acetylating spermidine 
and spermine, marking them for degradation or excretion. This ultimately restricts viral 
replication by depleting the cell of polyamines (24). Furthermore, studies have shown 
that SAT1 can be alternatively spliced in response to polyamine analogs and other 
pathophysiological agents including some RNA viruses (31). Our goal was to determine 
if ZIKV induces the alternative splicing of SAT1 to prevent the acetylation of higher-level 
polyamines. Our data suggests that during ZIKV infection, SAT1 is induced via 
interferon signaling but does not acetylate spermidine/spermine marking them for 
degradation or excretion from the cell. Furthermore, our data suggest that SAT1 is 
alternatively spliced, generating a longer variant with the addition of a 110 bp exon. This 
newly included exon creates a reading frame shift that introduces three premature stop 
codons and thus a truncated protein. We further demonstrated that this truncated 
protein might not be antiviral. We have generated a working model in which ZIKV 
utilizes polyamines during its infection cycle, as a way to combat this, type 1 interferon 




degradation or export from the cell. However, ZIKV can induce alternative splicing of 
SAT1, generating a truncated version which prevents the export of these polyamines, 
allowing the virus to use them during its lifecycle. (Figure 13).  
 
Figure 13. Proposed Model of SAT1 Alternative Splicing during ZIKV Infection. 
SAT1 is induced during a ZIKV infection through type 1 interferon signaling. SAT1 then 
acetylated spermidine/spermine marking them for degradation or export from the cell. 
ZIKV however, induces the alternative splicing of SAT1 generating a truncated version 
that does not result in the acetylation of these polyamines and thus allows the virus to 
use them during its lifecycle.  
 We further observed this phenotype in other RNA virus families, including 
bunyaviruses such as LACV and RVFV. Both of these also induced alternative splicing 
of SAT1 during infection. This indicates that this may be a conserved mechanism 
among viruses. In addition to bunyaviruses, other studies observed this alternative 
splicing of SAT1 in alphaviruses including Semliki Forest virus and Venezuelan equine 
encephalitis virus (28, 31).  
 Proposed Mechanism of Alternative Splicing of SAT1  
 During a viral infection, viral proteins work to subvert various cellular processes, 
remodels intracellular membranes, alters metabolic pathways to block the innate 




enzyme in polyamine regulation, could be another way the virus disarms the innate 
immune response. How the virus does this remains unknown and further investigation 
would be required to answer this question. However, recent studies have shown the 
NS5 protein of dengue virus (DENV), another flavivirus very similar to ZIKV, to interact 
with the spliceosome in infected cells. In this study, the researchers found the DENV 
NS5 protein to interact with the uridine-rich small nuclear ribonucleoprotein particles U5 
(U5 snRNP) to moderate splicing. They revealed differences in splicing of transcripts 
involved in innate immune responses and cell cycle control, including a few ISGs; 
however, SAT1 was not on the list of proteins they investigated (33). Another study, 
which delved into the molecular mechanism underlying SAT1 alternative splicing upon 
DENV infection found similar results to what our data suggests. The researchers 
observed lower protein levels of RBM10, a splicing factor responsible for SAT1 exon 4 
skipping, during infection. They reported the NS5 DENV protein interacts with RBM10 
and triggers RBM10 proteasome-mediated degradation. By over-expressing RBM10 in 
virus infected cells, they observed limited viral replication and no changes to SAT1 
splicing. Whereas RBM10 depletion resulted in increased SAT1 splicing and an 
increase in viral replication (34). Another study looked at the localization of ZIKV 
proteins during an infection and found the NS5 protein localizes to the nucleus and 
promotes trafficking of the splicing factor SC35 (35). This suggests that the ZIKV NS5 
protein may play a role in regulating the gene splicing process in host cells. During a 
viral infection, ZIKV relies on many host machinery and resources during its life cycle 
(18). We could hypothesize that it would be beneficial to disarm the interferon response 




the interferon response would be hindered for the benefit of the virus. Our data supports 
this hypothesis and includes SAT1 among other ISGs. By generating a non-functional 
SAT1, the polyamine levels, which ZIKV relies on, would not be diminished, allowing the 
virus to continue to use them and have a robust infection.  
Physiological Role of tSAT1 
The alternative splice variant of SAT1 has been reported during times of cellular 
stress, including X-ray irradiation (29), iron deficiency, or hypoxia (30). One study 
indicated that cells stably over-expressing the splice variant were protected from 
apoptosis under iron-deficient conditions (30). This brings into question the 
physiological role of the splice variant. One study showed that the splice variant is a 
target for non-sense mediated mRNA decay due to the introduction of three premature 
stop codons (28). This would ultimately prevent any production of new SAT1 protein to 
decrease polyamine levels. If the splice variant mRNA was not degraded, it would 
generate a truncated protein (termed here as tSAT1) that is only the first 71 N-terminal 
amino acids (31). tSAT1 would lack both the acetyl-CoA binding and catalytic motifs, 
which are essential for polyamine regulation (30). Another possibility of how tSAT1 
disrupts polyamine regulation is that active SAT1 is an oligomeric protein (36) and 
tSAT1 could bind to the enzyme as a defective subunit. This would, in turn, inhibit SAT1 
function. Regardless of how tSAT1 prohibits polyamine export and degradation, the 
alternative splicing of SAT1 may contribute to cell survival. Considering the splice 
variant has been induced during different unfavorable conditions, it is hypothesized to 
be a defense mechanism of the cell to prevent apoptosis (30). If this is the case, it is not 




replication and preventing cellular apoptosis would allow the virus to continue its 
lifecycle.  
It would be interesting to further explore the role of tSAT1 by generating a cell 
line carrying this truncated protein. This would allow for further investigation into its 
effects on polyamine levels in the cell. This cell line would also provide insight into if the 
truncated protein is antiviral or not. It would also be beneficial to generate a cell line 
carrying a version of SAT1 that cannot undergo alternative splicing. We further want to 
explore if the NS5 ZIKV protein is responsible for the alternative splicing of SAT1 as it 
has been suggested in DENV infection.  
While there are many avenues to explore involving the alternative splicing of 
SAT1 during a viral infection, our data has provided insight into the dynamic relationship 
between virus and host. Understanding how the virus neutralizes the innate immune 
system can provide insight into both the mechanisms of viral infection and the host 
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